DNTH — Dianthus Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Dianthus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	149	177	112	174	275
Net Total Accounts Receivable
Net Total Receivables	—	—	—	0.478	0.807
Prepaid Expenses
Total Other Current Assets
Total Current Assets	152	181	116	177	281
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.31	7.46	29.3	0.8	1.75
Long Term Investments
Other Long Term Assets
Total Assets	162	190	147	179	374
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11.4	10.9	14.5	9.63	18.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.7	17.3	40.7	10.5	21.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	144	173	106	169	352
Total Liabilities & Shareholders' Equity	162	190	147	179	374
Total Common Shares Outstanding